Literature DB >> 9393533

Renal cancer: preoperative evaluation with dual-phase three-dimensional MR angiography.

P L Choyke1, M M Walther, J R Wagner, W Rayford, J C Lyne, W M Linehan.   

Abstract

PURPOSE: To evaluate the use of dual-phase three-dimensional magnetic resonance (MR) angiography in the preoperative staging of renal cancer.
MATERIALS AND METHODS: MR angiography was performed in 18 patients before performance of partial (n = 7), radical (n = 10), or laparoscopic (n = 1) nephrectomy to treat renal cancer. Dynamic, three-dimensional MR angiograms were obtained with gadoteridol enhancement, breath holding, and a three-dimensional spoiled gradient-echo sequence. Images were obtained at 15-second intervals to achieve opacification of arteries and veins. Source, maximum intensity projection, and multiplanar reconstruction images were evaluated. Imaging results were compared with surgical findings.
RESULTS: Renal arterial phase MR angiograms depicted 30 of 31 (97%) surgically confirmed renal arteries, with one false-positive result (an artery that arose from an early-branching single main renal artery, interpreted as a separate accessory artery). Renal venous phase MR angiograms depicted all seven instances of renal vein involvement, including extension to the inferior vena cava in two patients. Collateral vessels around the tumor, including prominent gonadal veins in three patients, were demonstrated. Additional findings included adenopathy and adrenal and pulmonary metastases.
CONCLUSION: Dual-phase MR angiography of the kidney may be a useful technique in depicting renal vessels before nephrectomy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9393533     DOI: 10.1148/radiology.205.3.9393533

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  9 in total

Review 1.  Imaging angiogenesis of genitourinary tumors.

Authors:  Ying-Kiat Zee; James P B O'Connor; Geoff J M Parker; Alan Jackson; Andrew R Clamp; M Ben Taylor; Noel W Clarke; Gordon C Jayson
Journal:  Nat Rev Urol       Date:  2010-01-19       Impact factor: 14.432

Review 2.  Advances in medical imaging for the diagnosis and management of common genitourinary cancers.

Authors:  Mohammad H Bagheri; Mark A Ahlman; Liza Lindenberg; Baris Turkbey; Jeffrey Lin; Ali Cahid Civelek; Ashkan A Malayeri; Piyush K Agarwal; Peter L Choyke; Les R Folio; Andrea B Apolo
Journal:  Urol Oncol       Date:  2017-05-12       Impact factor: 3.498

Review 3.  Advanced renal mass imaging: diffusion and perfusion MRI.

Authors:  Anthony G Gilet; Stella K Kang; Danny Kim; Hersh Chandarana
Journal:  Curr Urol Rep       Date:  2012-02       Impact factor: 3.092

Review 4.  Contemporary imaging of the renal mass.

Authors:  Stella K Kang; Danny Kim; Hersh Chandarana
Journal:  Curr Urol Rep       Date:  2011-02       Impact factor: 3.092

Review 5.  [Differential diagnosis of renal tumors].

Authors:  P Hallscheidt; A Haferkamp; R Lopez-Benitez; M Palmowski
Journal:  Radiologe       Date:  2008-03       Impact factor: 0.635

6.  Evaluation of tumor thrombi in the inferior vena cava with intraoperative ultrasound.

Authors:  Carlo Trombetta; Giovanni Liguori; Stefano Bucci; Sara Benvenuto; Giulio Garaffa; Emanuele Belgrano
Journal:  World J Urol       Date:  2007-07-03       Impact factor: 4.226

Review 7.  Preoperative imaging in renal cell cancer.

Authors:  Axel Heidenreich; Vincent Ravery
Journal:  World J Urol       Date:  2004-07-30       Impact factor: 4.226

Review 8.  Applications of positron emission tomography imaging, intraoperative ultrasonography, magnetic resonance imaging, and angiography in the evaluation of renal masses.

Authors:  R Houston Thompson; Robert P Hartman; Val J Lowe; Akira Kawashima; Bradley C Leibovich
Journal:  Curr Urol Rep       Date:  2004-02       Impact factor: 2.862

9.  Radiologic evaluation of small renal masses (I): pretreatment management.

Authors:  A Marhuenda; M I Martín; C Deltoro; J Santos; Jose Rubio Briones
Journal:  Adv Urol       Date:  2009-03-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.